Stock Hero Advertisement
Home > Boards > US Listed > Biotechs > NorthWest Biotherapeutics (NWBO)

Here is the link to Germany DCVax Clinical

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
john1045 Member Profile
 
Followed By 22
Posts 1,754
Boards Moderated 0
Alias Born 06/09/11
160x600 placeholder
Advertisement
NW Bio Featured In Presentations At the American Association for Cancer Research Annual Meeting "PR Newswire (US)" - 4/20/2015 6:00:00 AM
NW Bio Included In New Index Of The "Top 25 Cancer Immunotherapy Companies" "PR Newswire (US)" - 4/16/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/14/2015 1:50:12 PM
NW BIO TO PRESENT AT WORLD VACCINE CONGRESS 2015 "PR Newswire (US)" - 4/9/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/8/2015 5:13:56 PM
CapRock Research Issues Analyst Report on Avra, Inc. (OTCQB: AVRN): Pioneering Product Innovation in Growing Bitcoin Market "InvestorsHub NewsWire" - 4/8/2015 8:00:00 AM
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 4/7/2015 5:03:44 PM
Disruptive Innovation Changing the Fight Against Cancer "The Motley Fool" - 4/5/2015 1:02:02 PM
NW Bio Announces $40 Million Financing "PR Newswire (US)" - 4/2/2015 11:55:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/30/2015 6:04:35 AM
NW BIO REPORTS PROMISING SURVIVAL DATA IN 51 GBM PATIENTS TREATED WITH DCVAX®-L "PR Newswire (US)" - 3/27/2015 9:00:00 AM
NW Bio To Present At The 2nd Immunotherapy Of Cancer Conference, ITOC-2 "PR Newswire (US)" - 3/24/2015 10:42:00 AM
Sonic Corp. Is A Terrific Stock - Cramer's Lightning Round (3/19/15) "Seeking Alpha" - 3/20/2015 5:04:08 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/17/2015 9:51:26 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 3/16/2015 5:22:38 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/23/2015 4:53:17 PM
NW BIO'S PHASE III TRIAL OF DCVAX®-L FOR GBM BRAIN CANCER APPROVED TO PROCEED IN CANADA AND UNDER WAY AT TWO SITES "PR Newswire (US)" - 2/19/2015 12:55:00 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/11/2015 5:01:44 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/10/2015 2:58:19 PM
NW Bio To Present At 17th Annual BIO CEO & Investor Conference "PR Newswire (US)" - 2/6/2015 9:15:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/5/2015 11:33:16 AM
NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum "PR Newswire (US)" - 1/23/2015 1:06:00 PM
NW Bio To Present At Biotech Showcase Conference "PR Newswire (US)" - 1/8/2015 2:46:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/30/2014 8:02:45 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/29/2014 4:35:32 PM
john1045   Monday, 12/24/12 04:47:16 PM
Re: None
Post # of 33918 
Here is the link to Germany DCVax Clinical trials with an area I pasted from long report so they obviously are recruiting over there as of now....

http://translate.google.com/translate?hl=en&sl=de&u=http://www.uniklinik-duesseldorf.de/fileadmin/Datenpool/einrichtungen/universitaetstumorzentrum_id505/neu2012/Dateien/Klinische_Studien_UTZ_Duesseldorf.pdf&prev=/search%3Fq%3Ddcvax%26start%3D50%26hl%3Den%26sa%3DN%26tbo%3Dd%26biw%3D1366%26bih%3D586%26tbs%3Dqdr:w&sa=X&ei=I8nYULiqM7GH0QGx6oDACg&ved=0CGwQ7gEwCTgy

Page 11 of 23

Clinical trials in brain tumors


IND No. 10206

Glioblastoma (brain cancer)

Phase II clinical trial to evaluate DCVax-Brain, autologous dendritic cells pulsed with tumor lysate, for treatment

of glioblastoma multiforme.



A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate for the Treatment of Glioblastoma

Multiforme

Your contact:

Prof. Dr. Michael Sabel

Michael.Sabel @ med.uni-duesseldorf.de



Page 12


Current clinical studies at University Cancer Center UTZ

University Cancer Center UTZ

Info Phone: 0211-8108200

at the University Hospital Dusseldorf

www.uniklinik-duesseldorf.de/utz

Stand: 01/2013

Page 12 of 23

Clinical trials in brain tumors

Fraunhofer Institute

Glioblastoma (brain cancer)

Phase II clinical study evaluating DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for

Treatment of glioblastoma multiforme (GBM)

Clinical phase II trial to evaluate DCVax ®-L Brain autologous dendritic cells loaded with tumor lysate antigen for treatment of glioblastoma

multiforme (GBM)

Your contact:

Infoline

Tel: 0211-8108200

uta@med.uni-duesseldorf.de


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist